| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
	      27
	    H
	      30
	    N
	      2
	    O
	      2
	    . Powder Diffraction , 1-6. 10.1017/s0885715625100869. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
	      24
	    H
	      28
	    N
	      3
	    O
	      4
	    Cl(H
	      2
	    O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of iprodione, C13H13Cl2N3O3. Powder Diffraction , 1-5. 10.1017/s0885715625100742. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of flumethasone, C22H28F2O5. Powder Diffraction , 1-6. 10.1017/s0885715625000120. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of diroximel fumarate, C11H13NO6. Powder Diffraction , 1-6. 10.1017/s0885715625000119. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2025). Crystal structure of etrasimod, C26H26F3NO3. Powder Diffraction , 1-6. 10.1017/s0885715625000107. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl. Powder Diffraction , 1-7. 10.1017/s0885715624000496. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of gepirone, C19H29N5O2. Powder Diffraction , 1-6. 10.1017/s0885715624000514. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaduk, James A.; Dosen, Anja; Blanton, Thomas (2025). Crystal structure of sparsentan, C32H40N4O5S. Powder Diffraction 40(2) , 157-161. 10.1017/s0885715625000132. | BXDS-WLE | Peer-Reviewed Article | Health | 
		
		    
    | Kaasalainen, Martti; Zhang, Ran; Vashisth, Priya; Birjandi, Anahid Ahmadi; S’Ari, Mark et al. (2024). Lithiated porous silicon nanowires stimulate periodontal regeneration. Nature Communications 15(1) . 10.1038/s41467-023-44581-5. | VLS-PGM | Peer-Reviewed Article | Health | 
		
		    
    | Judit Anido Folgueira; Patricia Anne Giblin; Robin Matthew Hallett; Jeanne Magram; Naimish PANDYA et al. (2024). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: AU2024204564A1. | CMCF-ID | Patent | Health | 
		
		    
    | Joshua Thomas Taylor (2024). Implementation of novel deep learning algorithms for the high-resolution study of the lacuno-canalicular network from individuals with a documented history of chronic opioid Use. Supervisor: Andronowski; Janna M.. Newfoundland and Labrador, Canada:  Memorial University of Newfoundland.  https://research.library.mun.ca/16691/. | BMIT-BM | Masters Thesis | Health | 
		
		    
    | Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US20250114475A1. | CMCF-ID | Patent | Health | 
		
		    
    | Jason Rolfe; Mehran Khodabandeh; Zaccary ALPERSTEIN; Seyed Ali Saberali; Hazem MSLATI et al. (2024). Protease inhibitors and methods of using same. Patent Number: WO2024130411A1. | CMCF-BM | Patent | Health |